000 | 02183 a2200565 4500 | ||
---|---|---|---|
005 | 20250514052626.0 | ||
264 | 0 | _c20030328 | |
008 | 200303s 0 0 eng d | ||
022 | _a0028-3835 | ||
024 | 7 |
_a10.1159/000066627 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aXiao, Dong | |
245 | 0 | 0 |
_aRegulation of growth hormone release in common carp pituitary cells by pituitary adenylate cyclase-activating polypeptide: signal transduction involves cAMP- and calcium-dependent mechanisms. _h[electronic resource] |
260 |
_bNeuroendocrinology _cNov 2002 |
||
300 |
_a325-38 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_a1-Methyl-3-isobutylxanthine _xpharmacology |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCalcimycin _xpharmacology |
650 | 0 | 4 |
_aCalcium _xmetabolism |
650 | 0 | 4 |
_aCalcium Channel Blockers _xpharmacology |
650 | 0 | 4 |
_aCalcium Channels, L-Type _xmetabolism |
650 | 0 | 4 | _aCarps |
650 | 0 | 4 |
_aColforsin _xpharmacology |
650 | 0 | 4 |
_aCyclic AMP _xmetabolism |
650 | 0 | 4 |
_aCyclic AMP-Dependent Protein Kinases _xmetabolism |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 |
_aEnzyme Activators _xpharmacology |
650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
650 | 0 | 4 |
_aGrowth Hormone _xdrug effects |
650 | 0 | 4 |
_aImines _xpharmacology |
650 | 0 | 4 | _aIn Vitro Techniques |
650 | 0 | 4 |
_aIonophores _xpharmacology |
650 | 0 | 4 |
_aIsoquinolines _xpharmacology |
650 | 0 | 4 |
_aNeuropeptides _xmetabolism |
650 | 0 | 4 |
_aNeurotransmitter Agents _xmetabolism |
650 | 0 | 4 |
_aNifedipine _xpharmacology |
650 | 0 | 4 |
_aPhosphodiesterase Inhibitors _xpharmacology |
650 | 0 | 4 | _aPituitary Adenylate Cyclase-Activating Polypeptide |
650 | 0 | 4 |
_aPituitary Gland _xdrug effects |
650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
650 | 0 | 4 | _aSulfonamides |
650 | 0 | 4 |
_aVasoactive Intestinal Peptide _xmetabolism |
700 | 1 | _aChu, Mable M S | |
700 | 1 | _aLee, Eric K Y | |
700 | 1 | _aLin, Hao-Ran | |
700 | 1 | _aWong, Anderson O L | |
773 | 0 |
_tNeuroendocrinology _gvol. 76 _gno. 5 _gp. 325-38 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1159/000066627 _zAvailable from publisher's website |
999 |
_c12263077 _d12263077 |